These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

155 related articles for article (PubMed ID: 34256665)

  • 1. Examining Conners Continuous Performance Test-3 (CPT-3) Embedded Performance Validity Indicators in an Adult Clinical Sample Referred for ADHD Evaluation.
    Scimeca LM; Holbrook L; Rhoads T; Cerny BM; Jennette KJ; Resch ZJ; Obolsky MA; Ovsiew GP; Soble JR
    Dev Neuropsychol; 2021 Aug; 46(5):347-359. PubMed ID: 34256665
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Examining embedded validity indicators in Conners continuous performance test-3 (CPT-3).
    Ord AS; Miskey HM; Lad S; Richter B; Nagy K; Shura RD
    Clin Neuropsychol; 2021 Nov; 35(8):1426-1441. PubMed ID: 32364040
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Settling the Score: Can CPT-3 Embedded Validity Indicators Distinguish Between Credible and Non-Credible Responders Referred for ADHD and/or SLD?
    Robinson A; Reed C; Davis K; Divers R; Miller L; Erdodi LA; Calamia M
    J Atten Disord; 2023 Jan; 27(1):80-88. PubMed ID: 36113024
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Aggregating validity indicators embedded in Conners' CPT-II outperforms individual cutoffs at separating valid from invalid performance in adults with traumatic brain injury.
    Erdodi LA; Roth RM; Kirsch NL; Lajiness-O'neill R; Medoff B
    Arch Clin Neuropsychol; 2014 Aug; 29(5):456-66. PubMed ID: 24957927
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Multivariate examination of embedded indicators of performance validity for ADHD evaluations: A targeted approach.
    Finley JA; Brooks JM; Nili AN; Oh A; VanLandingham HB; Ovsiew GP; Ulrich DM; Resch ZJ; Soble JR
    Appl Neuropsychol Adult; 2023 Sep; ():1-14. PubMed ID: 37703401
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Performance and symptom validity assessment in attention deficit/hyperactivity disorder: Base rates of invalidity, concordance, and relative impact on cognitive performance.
    Ovsiew GP; Cerny BM; Boer AB; Petry LG; Resch ZJ; Durkin NM; Soble JR
    Clin Neuropsychol; 2023 Oct; 37(7):1498-1515. PubMed ID: 36594201
    [No Abstract]   [Full Text] [Related]  

  • 7. A comparison of embedded validity indicators from the Stroop Color and Word Test among adults referred for clinical evaluation of suspected or confirmed attention-deficit/hyperactivity disorder.
    Khan H; Rauch AA; Obolsky MA; Skymba H; Barwegen KC; Wisinger AM; Ovsiew GP; Jennette KJ; Soble JR; Resch ZJ
    Psychol Assess; 2022 Jul; 34(7):697-703. PubMed ID: 35357873
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Assessing performance validity during attention-deficit/hyperactivity disorder evaluations: Cross-validation of non-memory embedded validity indicators.
    Ausloos-Lozano JE; Bing-Canar H; Khan H; Singh PG; Wisinger AM; Rauch AA; Ogram Buckley CM; Petry LG; Jennette KJ; Soble JR; Resch ZJ
    Dev Neuropsychol; 2022 Aug; 47(5):247-257. PubMed ID: 35787068
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Cross-validating the Clinical Assessment of Attention Deficit-Adult symptom validity scales for assessment of attention deficit/hyperactivity disorder in adults.
    Finley JA; Cerny BM; Brooks JM; Obolsky MA; Haneda A; Ovsiew GP; Ulrich DM; Resch ZJ; Soble JR
    J Clin Exp Neuropsychol; 2024 Mar; 46(2):111-123. PubMed ID: 37994688
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Cross-validating the Dot Counting Test Among an Adult ADHD Clinical Sample and Analyzing the Effect of ADHD Subtype and Comorbid Psychopathology.
    Abramson DA; White DJ; Rhoads T; Carter DA; Hansen ND; Resch ZJ; Jennette KJ; Ovsiew GP; Soble JR
    Assessment; 2023 Mar; 30(2):264-273. PubMed ID: 34643101
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Further examination of embedded performance validity indicators for the Conners' Continuous Performance Test and Brief Test of Attention in a large outpatient clinical sample.
    Sharland MJ; Waring SC; Johnson BP; Taran AM; Rusin TA; Pattock AM; Palcher JA
    Clin Neuropsychol; 2018 Jan; 32(1):98-108. PubMed ID: 28548557
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The Divergent Roles of Symptom and Performance Validity in the Assessment of ADHD.
    White DJ; Ovsiew GP; Rhoads T; Resch ZJ; Lee M; Oh AJ; Soble JR
    J Atten Disord; 2022 Jan; 26(1):101-108. PubMed ID: 33084457
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Not so fast! Limitations of processing speed and working memory indices as embedded performance validity tests in a mixed neuropsychiatric sample.
    Ovsiew GP; Resch ZJ; Nayar K; Williams CP; Soble JR
    J Clin Exp Neuropsychol; 2020 Jul; 42(5):473-484. PubMed ID: 32498648
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Relations between Continuous Performance Test performance measures and ADHD behaviors.
    Epstein JN; Erkanli A; Conners CK; Klaric J; Costello JE; Angold A
    J Abnorm Child Psychol; 2003 Oct; 31(5):543-54. PubMed ID: 14561061
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Further Validation of the Conner's Adult Attention Deficit/Hyperactivity Rating Scale Infrequency Index (CII) for Detection of Non-Credible Report of Attention Deficit/Hyperactivity Disorder Symptoms.
    Cook CM; Bolinger E; Suhr J
    Arch Clin Neuropsychol; 2016 Jun; 31(4):358-64. PubMed ID: 27193367
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Does the Conners' Continuous Performance Test aid in ADHD diagnosis?
    McGee RA; Clark SE; Symons DK
    J Abnorm Child Psychol; 2000 Oct; 28(5):415-24. PubMed ID: 11100916
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Cross-validation of non-memory-based embedded performance validity tests for detecting invalid performance among patients with and without neurocognitive impairment.
    White DJ; Korinek D; Bernstein MT; Ovsiew GP; Resch ZJ; Soble JR
    J Clin Exp Neuropsychol; 2020 Jul; 42(5):459-472. PubMed ID: 32397824
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Embedded validity indicators in Conners' CPT-II: Do adult cutoffs work the same way in children?
    Erdodi LA; Lichtenstein JD; Rai JK; Flaro L
    Appl Neuropsychol Child; 2017; 6(4):355-363. PubMed ID: 27383142
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Differentiating Performance on the Connors Continuous Performance Test (CPT-3) as a Function of Comorbid Internalizing Psychopathology.
    Brooks JM; Guilfoyle J; Alfonso D; Oh A; Nili AN; Frick LA; Resch ZJ; Soble JR; Ulrich DM
    J Atten Disord; 2024 Apr; 28(6):1024-1031. PubMed ID: 38214177
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Validating Embedded Validity Indicators of Feigned ADHD-Associated Cognitive Impairment Using the MOXO-d-CPT.
    Winter D; Braw Y
    J Atten Disord; 2022 Dec; 26(14):1907-1913. PubMed ID: 35861241
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.